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Abstract
Background: France stands among high-risk areas for colorectal cancer. Different trends in CRC incidence are
reported around the world. The aim of this study was to provide temporal trends in CRC incidence over a 30-year
period in a French well-defined population.
Methods: Between 1976 and 2005, 17,028 new cases were registered by the Burgundy digestive cancer registry.
The mean variations in age-standardized incidence rates were estimated using a Poisson regression adjusted for
age for each gender and location. The cumulative risk by birth cohort of developing a cancer over the age range
0-74 years was estimated using an age-cohort model.
Results: Incidence rates for right and left colon cancers increased more rapidly in males (respectively +11.7% and
+10.3% on average by 5-year period) than in females (respectively +5.9% and +6.1%). It remained stable for
sigmoid cancers in males (-0.1%) and decreased in females (-5.2%). It also decreased for rectal cancers both in
males (-2.7%) and in females (-2.0%). The cumulative risk increased from 3.9% for males born around 1900 to 4.9%
for those born around 1930 and then slightly decreased (4.5% among those born around 1950). It remained at the
same level for females born around 1900 (2.7%) as for those born around 1930 (2.7%) and then slightly increased
(2.9%) for those born around 1950. For right colon cancers, the cumulative risk increased strikingly in successive
birth cohorts from 0.53% to 1.2% in males and 0.55% to 0.77% in females. The corresponding cumulative risks for
the left colon were 0.24% and 0.42% in males and 0.14% and 0.29% in females. For sigmoid cancer, they decreased
from 1.59% to 1.08% in males, and 0.88% to 0.80% in females.
Conclusion: Temporal variations in incidence rates of colorectal cancers differed according to subsite, suggesting
different aetiological factors and implications for diagnosis and screening strategies. Total colonoscopy must be the
preferred strategy in high-risk groups or after a positive faecal occult blood test.
Background
In France, colorectal cancer is currently the third most
common cancer in men and the second in women [1].
In 2005, the number of new cases was estimated to be
37,413 for both genders with age-standardized rates of
37.7/100,000 in males and 24.5/100,000 in females [1].
Incidence in France is comparable to that found in
other high-risk areas of Western Europe, North Amer-
ica, Australia/New Zealand, and Japan [2], whereas it
remains lower in Africa and Asia. Colorectal cancers
were long considered to be a homogeneous entity, but
several studies suggest that their characteristics differ by
anatomical subsites [3,4]. Temporal trends in incidence
are related to three main factors: age, period of diagno-
sis and birth cohort. Study of colorectal cancers using
age-period cohort models is commonly used in order to
better understand the observed trends and aetiological
factors connected with them [5,6]. These models also
allow estimation of the cumulative risk of developing a
colorectal cancer for a given birth cohort [7]. The aim
of this paper is to provide updated temporal trends in
colorectal cancer incidence over a 30-year period in a
well-defined French population, and to specifically * Correspondence: anne-marie.bouvier@u-bourgogne.fr
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Methods
Patients
The Digestive Cancer Registry records all digestive tract
cancers diagnosed in two administrative districts of Bur-
gundy, France (1,052,000 inhabitants according to the
1999 census). The French National Commission of Data
Processing and Civil Liberty (CNIL) authorized the Reg-
istry to lead incidence studies. Cancer registration began
in 1976 in the Côte-d’Or area and in 1982 in the Saône-
et-Loire area. Information is routinely collected from
pathology laboratories, university hospitals, local hospi-
t a l s ,p r i v a t es u r g e o n s ,o n c o l o g i s t s ,g a s t r o e n t e r o l o g i s t s
and general practitioners, French National Health Ser-
vice records to identify patients treated outside these
areas, and monthly reviews of death certificates. Cases
are not recorded through death certificates alone, but
these are used to identify missing cases. Since informa-
tion is obtained from numerous sources, we assumed
that nearly all newly diagnosed cases were recorded.
Registration quality and comprehensiveness is certified
every 4 years by an audit of the National Institute for
Health and Medical Research (INSERM) and the
National Public Health Institute (InVS). A total of
17,028 cases, over a 30-year period, were registered.
Cancer location was defined according to the Interna-
tional Classification of Diseases for Oncology [8]. The
cases were grouped into 4 categories: (1) Right colon
cancers (C18.0, C18.2, C18.3, C18.4) represented 28.2%
of cases (2) Left colon cancers (C18.5, C18.6) repre-
sented 7.2% of cases [3]. Sigmoid cancers (C18.7) repre-
sented 25.8% of cases and (4) Rectum and rectosigmoid
junction (C19.9, C20.9) cancers represented 38.1% of
cases. Colon cancer with no other information (C18.9)
represented 0.7% of cases.
Data analysis
The population data used for calculating incidence rates
was obtained from the Institut National de Statistiques
et des Etudes Economiques (INSEE). All rates were cal-
culated by gender and age group. For the purpose of
comparison with other countries, rates were age-stan-
dardized by the direct method using the world standard
population. Incidence was calculated for the entire
1976-2005 period and for each successive 5-year period.
Average variations in incidence rates for the 5-year peri-
ods were estimated using a Poisson regression, adjusted
for age for each gender and location. Patients were
grouped according to their year of birth into birth
cohorts. Each birth cohort covered 5 successive years of
births. Results start with the 1900 birth cohort, which
comprised the five years of births from 1898 to 1902, up
to the 1950 birth cohort, which comprised the years
1948 to 1952. Time trends by birth cohort were esti-
mated using an age-cohort model [5,6]. Poisson regres-
sion, in which the number of cancer cases are modelled
as a function of age and birth cohort, was the model
used [8]. For each location, the most suitable model was
used to estimate by birth cohort the 0-74 year cumula-
tive risk of developing a cancer, according to the likeli-
hood ratio test at the 0.05 level. The cohort-specific
cumulative risk of colorectal cancer is the risk of devel-
oping this disease for an individual of the cohort who
had survived up to 74 years [9]. It is the sum other each
year of age of the age-specific incidence rates taken
from birth to age 74. Data were analyzed using Stata
10.0 ™ software [10].
Results
Time trends in incidence rates by period of diagnosis
Overall, the average variation in CRC incidence rates
between successive five-year periods was +1.9% [95%CI:
+0.6; +3.2] in males and + 0.3% [95%CI: -1.1; +2.8] in
females. The trends in incidence varied according to
subsite as shown in Table 1. Between successive 5-year
periods, incidence rates increased significantly for right
colon and left colon cancer for both genders. The aver-
age increase by 5-year period was greater in males,
respectively +11.7% and +10.3%, than in females, respec-
tively +5.9% and. +6.1%. In contrast, for sigmoid can-
cers, there were different trends for the two genders:
incidence was stable in males and decreased in females.
For rectal cancer, the incidence decreased significantly
in males (-2.7% on average) and non significantly in
females (-2.0% on average). Across the study period, the
male-female ratio remained higher than 1 for all sub-
sites. It tended to slightly increase for colon subsites.
Time trends in incidence rates by birth cohort
In males, the cumulative risk rose from 3.9% among
those born around 1900 to 4.9% for those born around
1930 and then slightly decreased to 4.5% among those
born around 1950. In contrast, it remained at the same
level for females born around 1900 as for those born
around 1930 (2.7% for both cohorts) and then slightly
increased (2.9%) for females born around 1950.
The cumulative risk of developing right colon cancer
over the age range 0-74 years has increased strikingly in
successive birth cohorts (Table 2). It rose from 0.53%
for males born around 1900 to 1.20% for those born
around 1950, a 2.3-fold increase. The corresponding
values in females were 0.55% and 0.77%, a 1.4-fold
increase. There was a similar trend for the risk of devel-
oping left colon cancer over the age range 0-74 years.
T h e r ew a sa1 . 8 - f o l di n c r e a s ei nm a l e sa n da2 . 1 - f o l d
increase in females. In contrast there was a decrease in
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between those born around 1900 and those born around
1950. For sigmoid cancers, there was a 1.5-fold decrease
in males born around 1950 and a 1.1-fold decrease in
females. For rectal cancers there was also a 1.5-fold
decrease in the cumulative risk in males. In females, the
risk decreased between those born around 1900 to those
born around 1930. It then increased for those born after
1930 to reach the same level as for those born around
1900.
Discussion
Over a 30-year period, the overall incidence of colorec-
tal cancer in France has slightly increased in males and
remained stable in females. In the youngest birth
cohorts the cumulative risk over the age range 0-74
years slightly decreased in males whereas it slightly
increased in females. The most impressive aspect of our
study was the marked increase in the incidence rates of
right and left colon cancers both by time period and
birth cohort. The cumulative risk of sigmoid and rectal
cancers decreased in males while it remained relatively
stable in females.
The Burgundy registry is the most longstanding popu-
lation-based digestive cancer registry in France. The
multiplicity of information sources allows us to assume
that nearly all newly diagnosed cancers are recorded.
Thus, it is an appropriate tool for observing time trends
in incidence rates. When analyzing 30 years of inci-
dence, it is necessary to evaluate the comparability of
data over such a long period. The strength of our results
lies in the fact that the registration scheme and the cod-
ing rules remained the same over the study period.
Colonoscopy has progressively replaced barium enema
as a diagnostic procedure. However, this was unlikely to
explain time trends in incidence.
Five volumes of the publication Cancer Incidence in
Five Continents provide data on time trends on colorec-
tal cancer incidence over the period covered by this
paper [11-15]. Different trends in CRC incidence can be
Table 2 Cumulative risk over the age range 0-74 years of developing colorectal cancer by gender and subsite
according to birth cohort
1900 1905 1910 1915 1920 1925 1930 1935 1940 1945 1950
Males
All sites 3.94 4.20 4.42 4.60 4.73 4.82 4.85 4.83 4.75 4.63 4.46
Right Colon 0.53 0.62 0.72 0.82 0.92 1.01 1.09 1.15 1.19 1.21 1.20
Left Colon 0.24 0.26 0.29 0.31 0.33 0.35 0.37 0.39 0.40 0.41 0.42
Sigmoid 1.59 1.56 1.52 1.48 1.44 1.39 1.33 1.27 1.21 1.15 1.08
Rectum 2.44 2.42 2.39 2.33 2.26 2.18 2.08 1.97 1.86 1.74 1.61
Females
All sites 2.68 2.67 2.66 2.66 2.67 2.68 2.70 2.73 2.76 2.80 2.85
Right Colon 0.55 0.61 0.66 0.71 0.75 0.78 0.80 0.81 0.81 0.80 0.77
Left Colon 0.14 0.15 0.15 0.17 0.18 0.19 0.21 0.22 0.24 0.27 0.29
Sigmoid 0.88 0.82 0.78 0.74 0.72 0.71 0.71 0.72 0.73 0.76 0.80
Rectum 1.09 1.04 1.00 0.97 0.95 0.94 0.95 0.96 0.98 1.01 1.05
Table 1 Age-standardized incidence rates by gender, subsite and period of diagnosis
Incidence rates by periods of diagnosis Average variation
76-80 81-85 86-90 91-95 96-00 01-05 % [95% CI]
Males
All sites 34.9 37.9 40.8 40.0 41.5 40.3 + 1.9 [0.6; 3.2]
Right Colon 5.9 7.4 7.8 9.2 10.3 10.2 + 11.7 [8.6; 14.8]
Left Colon 1.8 2.3 3.0 2.8 3.0 3.7 + 10.3 [5.0; 15.8]
Sigmoid 9.6 10.1 12.0 10.2 11.0 10.6 - 0.1 [-2.5; 2.4]
Rectum 17.7 17.7 17.7 17.5 17.0 15.7 - 2.7 [-4.7; -0.8]
Females
All sites 21.9 23.3 22.8 23.2 23.3 23.1 +0.3 [-1.1; 2.8]
Right Colon 5.6 5.9 6.6 6.8 7.7 7.1 + 5.9 [3.3; 8.6]
Left Colon 1.3 1.6 2.0 1.5 1.9 2.0 + 6.1 [0.4; 12.1]
Sigmoid 5.6 7.5 6.6 5.9 5.5 6.1 - 5.2 [-7.9; -2.5]
Rectum 9.3 8.1 7.5 8.6 8.1 7.8 -2.0 [-4.5; 0.4]
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rates were stable or slightly increased, with the excep-
tion of Norway and Spain where the increase in inci-
dence was more pronounced. Incidence is generally on
the increase in East European countries, Central and
South America and in Asia. The most prominent feature
was the sharp increase in incidence in Japan, which now
stands among high-risk areas [16]. After an increase in
incidence until the late 1980s, a decrease in incidence
was reported in the USA, while it remained stable in
Canada. Incidence rates were also stable in Australia
and New Zealand [17].
Availability of incidence rates by subsites is more lim-
ited. Evidence exists for different time trends, in particu-
lar among high-risk areas. In the USA, stable incidence
rates for right colon cancer, and declining rates for left
colon (descending and sigmoid) and rectal cancer were
reported over the 1992-2001 period [18]. Data covering
the 1997-2006 period indicates that all CRCs are now
significantly declining in the US [19]. Among available
data in Europe, an increase in all colon subsites was
reported in Denmark [4,20], Norway [21] and Italy
[22,23], whereas in Burgundy, the increase was limited
to right and left colon cancers. A recent study from
Norway reveals deceleration in the rate of increase of
colon cancer subsites [24]. In most high-risk areas, the
incidence of rectal cancer decreased (USA, Denmark,
France) or was stable (Italy, Australia), whereas it
increased in Norway [24-27]. In low-risk areas of Asia,
Central and South America, there was a striking
increase in incidence of all colon subsites, while it was
moderate for rectal cancers [11-15].
Most studies on trends in colorectal cancer incidence
are limited to analysis by period of diagnosis. Trends by
birth cohort bear different implications and are thus
complementary. Effects of both period of diagnosis and
birth cohort were found in this study, as well as in other
studies [21,26,27]. However for sigmoid cancers the
birth cohort effect was more marked in males and the
period of diagnosis effect in females. Exposure to early-
s t a g er i s kf a c t o ro rp r o t e c t ive factor with long-term
latency periods over different generations will introduce
a cohort effect. A period of diagnosis effect can be
attributed to risk factors or protective factors involved
in the late stage of carcinogenesis affecting all age
groups, or to changes in screening practices. The pro-
tective role of vegetables reported in case control studies
(and not in cohort studies) could be attributed to a per-
iod effect. Case control studies, concerning recent
intakes, provide data on dietary factors involved in the
last phase of colorectal carcinogenesis, while cohort’s
studies provide data on the early phase of this colorectal
carcinogenesis. Dietary factors affecting the last step of
the adenoma-carcinoma sequence can modify cancer
risk in a relatively short period of time. An example of
this period effect is given by the westernisation of diet
in Japan. It became a high-risk country for colorectal
cancer in about 15 years following changes in dietary
behaviour [28]. A similar effect was observed in Japanese
migrants to the USA [29]. There are discrepancies
between case-control and cohort studies, but these are
not surprising. Cohort studies collecting data on diet a
long time before the appearance of the cancer are able
to identify the main dietary factors related to the cohort
effect, while case-control studies that take recent diet
into account reveal factors related to the period effect.
There is a tendency to consider that in case of discre-
pancies, cohort studies are more representative of the
truth. As factors involved in adenoma appearance or
growth differ, at least partly, from those involved in ade-
noma transformation, then cohort and case control stu-
dies should provide somewhat different results.
Data from the United States suggest an impact of
screening on the decline in mortality and incidence
from CRC. The 2010 US annual report to the Nation on
the status of cancer provides the results of a simulation
model for interpreting mortality trends for CRC. The
results suggest that 35% of the observed mortality
decline can be explained by changes in risk factors, 53%
by screening and 12% by improvement in treatment
[19]. However, the impact on incidence rates can only
be seen after a long time lag [30]. In a cohort of patients
with adenomas measuring more than 1 cm in diameter
that remained in the colon, the cumulative colon cancer
rate was 8% after 10 years and 24% after 20 years [31].
The marked decrease in the incidence of CRC in the
US, between 1985-1995 cannot be attributed to screen-
ing, which was not widespread in the 15-20 years pre-
ceding that period. Changes in risk factors or protective
factors probably played the most important role. A sig-
nificant positive effect of screening on CRC mortality or
incidence can be expected only during the most recent
period. The decline in CRC incidence could be acceler-
ated further by higher utilisation of screening. Trends in
incidence in Europe cannot be related to screening prac-
tices because of too recent development of screening
programmes. For instance Norway has not undertaken
CRC screening programmes and less than 5% of colo-
noscopies performed are related to CRC screening [24].
The different time trends by subsite within areas, and
among areas with similar overall CRC incidence, suggest
that dietary factors involved in CRC carcinogenesis
along the length of the colon might differ, at least partly,
and that the protecting or enhancing factors may differ
from one area of the world to another. For instance
meat consumption is a more important risk factor in
North America or Australia where consumption is
higher than in Europe, and refined cereal consumption
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Latin European countries where consumption of these
products is high [32]. There are also data indicating that
aetiological factors may differ along the large bowel. In
a case-control study performed in the Côte-d’Or area,
t h ep r o t e c t i v ee f f e c to fh i g hv e g e t a b l ei n t a k ew a s
restricted to the sigmoid colon. Factors that might be
more linked to right colon cancer include body mass
index. It has increased over the past few decades in
France. The increased incidence of right colon cancer
could be related to the increase in obesity.
Conclusions
The strength of our study lies in the fact that it is a
population-based study, using high-quality cancer regis-
try data collected over a 30-year period, with time
trends analysed both by period and birth cohort. Inci-
dence rates in Burgundy are similar to those reported at
the national level [1]. So we feel that our findings can
be generalised to the French population overall. This
study shows that the incidence increased in males and
was stable in females over the 1976-2005 period. In
revealing different time trends in incidence for subsites
and genders, our results suggest that CRCs have, at least
in part, different aetiological factors. Differences are also
reported among cancer registries. Since colorectal can-
cer is one of the most common cancers it is important
to conduct future studies that take into account envir-
onmental, genetic and molecular factors. The shift
towards right colon cancers reported here has implica-
tions for the choice of colorectal cancer screening
methods.
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